A humanized monoclonal antibody (IgG1) raised against amyloid beta peptides with Alzheimer disease treatment application. Bapineuzumab recognizes and binds the N-terminal amino acids 1-5 of the amyloid beta peptide, and may be used in a passive immunotherapy treatment.
Synonyms: AAB-001 Anti-human beta-amyloid Monoclonal Antibody 3D-6 Humanized 3D-6 Monoclonal Antibody BAPINEUZUMAB Bapineuzumab
This is just here as a test because I lose it
Term information
Subsets
NCIT_C63923